Identification of lymphocyte subgroups with flow cytometry in COVID-19 patients

dc.contributor.authorBerber, İlhami
dc.contributor.authorBerber, Nurcan Kırıcı
dc.contributor.authorSarıcı, Ahmet
dc.contributor.authorBağ, Harika Gözükara
dc.contributor.authorBiçim, Soykan
dc.contributor.authorTurgut, Burhan
dc.contributor.authorKuku, İrfan
dc.date.accessioned2026-08-12T15:11:50Z
dc.date.issued2022
dc.departmentFırat Üniversitesi
dc.description.abstractObjective: We aimed to determine lymphocyte subgroups and activation status of flow cytometry in COVID-19 patients and examine their relationship with disease stage and length of hospital stay. Material and Method: Forty patients were analyzed in this study and compared with the age and sex-matched 40 healthy controls. COVID-19 patients have split as early and advanced-stage diseases. Flow cytometry assay was performed to determine the counts of lymphocyte subsets and activation status. Total lymphocyte count was calculated and CD45 (cluster of differentiation), CD3, CD4, CD8, CD19, CD27, CD38, CD56, CD57, and IgD were studied on lymphocyte gate. T helper / T cytotoxic rates and length of hospital stay were recorded. Results: The patients' CD3(+)CD4(+) ( T helper) count and CD27 expression on T cells counts were significantly lower, and CD57 expression on CD3(+)CD8(+) T cytotoxic cells were significantly higher (p
dc.identifier.doi10.32322/jhsm.1129894
dc.identifier.endpage1189
dc.identifier.issn2636-8579
dc.identifier.issue4
dc.identifier.startpage1183
dc.identifier.urihttps://doi.org/10.32322/jhsm.1129894
dc.identifier.urihttps://hdl.handle.net/11508/30294
dc.identifier.volume5
dc.language.isoen
dc.publisherMediHealth Academy Yayıncılık
dc.relation.ispartofJournal of Health Sciences and Medicine
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_DergiPark_20260511
dc.subjectHealth Care Administration
dc.subjectSağlık Kurumları Yönetimi
dc.titleIdentification of lymphocyte subgroups with flow cytometry in COVID-19 patients
dc.typeArticle

Dosyalar